Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 2/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.71 |
| ▸ | HPGD | P15428 | 1/20 | 0.71 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.71 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.71 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14441049 | 1.00 | OPRD1 (0.71) | OPRD1CYP1A2CYP3A4CYP2C9HPGD | |
| SCHEMBL12018148 | 1.00 | OPRD1 (0.71) | OPRD1CYP1A2CYP3A4CYP2C9HPGD | |
| SCHEMBL4576661 | 1.00 | OPRD1 (0.71) | OPRD1CYP1A2CYP3A4CYP2C9HPGD | |
| SCHEMBL5300566 | 1.00 | OPRD1 (0.71) | OPRD1CYP1A2CYP3A4CYP2C9HPGD | |
| SCHEMBL12017985 | 0.94 | OPRD1 (0.76) | OPRD1CYP1A2CYP3A4CYP2C9HPGD | |
| SCHEMBL12017979 | 0.93 | OPRD1 (0.72) | OPRD1CYP1A2CYP3A4CYP2C9HPGD | |
| SCHEMBL12018160 | 0.93 | OPRD1 (0.72) | OPRD1CYP1A2CYP3A4CYP2C9HPGD | |
| SCHEMBL3111930 | 0.93 | OPRD1 (0.72) | OPRD1CYP1A2CYP3A4CYP2C9HPGD | |
| SCHEMBL4576944 | 0.93 | OPRD1 (0.72) | OPRD1CYP1A2CYP3A4CYP2C9HPGD | |
| SCHEMBL4576255 | 0.93 | OPRD1 (0.72) | OPRD1CYP1A2CYP3A4CYP2C9HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1469850-B1 | METHOD OF TREATING SEXUAL DYSFUNCTIONS WITH DELTA OPIOID RECEPTOR AGONIST COMPOUNDS | VERSI GROUP LLC (US) | 2013-01-02 | — | — | EP | disclosed |